2024 Education course (full-day)
Development of pluripotent stem cell-based platforms for disease modeling and therapies
Saturday, May 4
8am – 4:30pm PT
Seattle Convention Center - Arch Building
Organizer
- Holly Chen, PhD — University of Alabama at Birmingham.
Audience
Researchers who want to: (1) learn more about the recent advances and applications of pluripotent stem cell-based platforms; (2) implement this cutting-edge technology for disease modeling and/or therapies in their research.
Description
Pluripotent stem cell-derived retinal tissues exhibit morphological resemblance and significant functional parallels to in vivo retinal structures, presenting a promising in vitro platform. Nevertheless, a notable disparity persists between the current maturity of this platform and its potential therapeutic applications. This course will comprehensively introduce various types of pluripotent stem cell-derived tissues and update the audience with the recent advances. It will also provide examples of how to apply pluripotent stem cell-based platforms to evaluate therapies. Finally, a panel discussion will provide an opportunity for networking and in-depth discussion between speakers and audience to address specific projects.
After attending this course, you will be able to:
- Describe various approaches to generate pluripotent stem cell-derived retinal tissues
- Outline current advances and future directions in stem cell technologies
- Describe the latest updates and developments in ARVO, AAO, and NEI initiatives for AI and big data in ophthalmology and visual sciences
- Recognize the pros and cons of pluripotent stem cell-based approaches
- Design pluripotent stem cell-based platform for developing therapies
Course fee
* Breakfast and lunch included with full-day course registration
| Full-day course fee |
Up to March 8 |
March 9 - April 26 |
After April 26 |
| Member | $235 | $290 | $320 |
| Member-in-training | $175 | $200 | $220 |
| Nonmember | $310 | $365 | $395 |
| Nonmember-in-training | $215 | $240 | $260 |
Physician accreditation statement
The Association for Research in Vision and Ophthalmology (ARVO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physician credit designation
ARVO designates this live activity for a maximum of 7 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
International Attendees: The American Medical Association (AMA) has determined that physicians not licensed in the U.S. who participate in CME activities are eligible for AMA PRA Category 1 Credits™.